Aspen Notre-Dame-de-Bondeville recognizes worldwide as pharmaceutical reference site for sterile products since 50 years.

We manufacture and ship worldwide Fraxiparine™, Arixtra™, MonoEmbolex™ but also diluents used for reconstitution of vaccines prior to injection.

In 2018, the site commits to the manufacture of injectable anesthetic products.

We full master the criteria that ensure the absence of risk for the patient.

Every day and in each of our actions, we think of patients, they are counting on us.


1968 Foundation

3 Active ingredients

6 Products

720 Employees

100 Millions euros of investments committed for the coming years

92% of our production is shipped overseas

Our certifications: ANVISA (Brazil), ANSM (France), EMA (Europe), FDA (USA), HPB (Canada), JMHRA (Japan)

Aspen has a Management System certified by DQS for OHSAS 18001 (Health / Safety) and ISO 14001 (Environment) standards

Investor/Investisseurs Information


Site Presentation

Download PDF